Pneumocystis carinii (Pc) remains a major cause of morbidity and occasional mortality in HIV infected patients. Bronchoscopy with bronchoalveolar lavage (BAL) allows for studying the lung in symptomatic patients. With lavage, the diagnosis of Pc is usually made. In addition, lavage provides a source of Pc specimen to be studied. We plan to continue our policy of collecting and handling BAL specimens in a standardized fashion at our institution. This standard analysis has provided useful clinical information, and has been used to provide samples for research use. The proposed research will examine BAL samples in three areas: organism analysis (including quantitation, viability, and molecular karyotyping), immunologic identification (evaluation of monoclonal and polyclonal antibodies against various antigens of rat and human Pc), and immune response (as assessed by the inflammatory nature of the lavage cells as well as systemic antibodies). These techniques, along with the clinical information obtained on these patients will allow to study these hypotheses: (1) BAL remains useful in diagnosing Pc pneumonia in HIV infected patients; (2) Follow-up BAL is useful in assessing response to therapy; (3) Analysis of local and systemic immune response to Pc pneumonia provides diagnostic and prognostic information; (4) Recurrent Pc infection represents reinfection rather than reactivation of latent organisms; (5) The characterization of the Pc isolates will predict virulence and antimicrobial sensitivity; (6) Characteristics of Pc isolates vary with geographical and sociologic conditions.

Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Cincinnati
Department
Type
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Grady, Benjamin J; Torstenson, Eric S; McLaren, Paul J et al. (2011) Use of biological knowledge to inform the analysis of gene-gene interactions involved in modulating virologic failure with efavirenz-containing treatment regimens in ART-naïve ACTG clinical trials participants. Pac Symp Biocomput :253-64
Sherman, Kenneth E; Rouster, Susan D; Stanford, Sandra et al. (2010) Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens. J Infect Dis 201:712-9
Bhattacharya, Debika; Umbleja, T; Carrat, F et al. (2010) Women experience higher rates of adverse events during hepatitis C virus therapy in HIV infection: a meta-analysis. J Acquir Immune Defic Syndr 55:170-5
Zhao, Yu; Navia, Bradford A; Marra, Christina M et al. (2010) Memantine for AIDS dementia complex: open-label report of ACTG 301. HIV Clin Trials 11:59-67
Fichtenbaum, Carl J; Yeh, Tzu-Min; Evans, Scott R et al. (2010) Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087. J Clin Lipidol 4:279-87
Winham, Stacey J; Slater, Andrew J; Motsinger-Reif, Alison A (2010) A comparison of internal validation techniques for multifactor dimensionality reduction. BMC Bioinformatics 11:394
Butt, Adeel A; Tsevat, Joel; Leonard, Anthony C et al. (2009) Effect of race and HIV co-infection upon treatment prescription for hepatitis C virus. Int J Infect Dis 13:449-55
Tsevat, Joel; Leonard, Anthony C; Szaflarski, Magdalena et al. (2009) Change in quality of life after being diagnosed with HIV: a multicenter longitudinal study. AIDS Patient Care STDS 23:931-7
Skowron, Gail; Spritzler, John G; Weidler, Jodi et al. (2009) Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects. J Acquir Immune Defic Syndr 50:250-8
Sattler, Fred R; Rajicic, Natasa; Mulligan, Kathleen et al. (2008) Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial. Am J Clin Nutr 88:1313-21

Showing the most recent 10 out of 123 publications